ArticleFrontiers in oncology2022

Corrigendum: Progression-free survival and time to progression as potential surrogate endpoints for overall survival in chemoradiotherapy trials in limited-stage small-cell lung cancer: A systematic review and meta-analysis.

Yin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.